On November 11, 2021 Bicycle Therapeutics plc (NASDAQ: BCYC), a biotechnology company pioneering a new and differentiated class of therapeutics based on its proprietary bicyclic peptide (Bicycle) technology, reported that management will participate in the following investor conferences in November and December (Press release, Bicycle Therapeutics, NOV 11, 2021, View Source [SID1234595193]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Jefferies London Healthcare Conference on Friday, November 19, 2021; pre-recorded fireside chat available on demand at 3:00 a.m. ET on Thursday, November 18, 2021
Piper Sandler 33rd Annual Healthcare Conference on Thursday, December 2, 2021; pre-recorded fireside chat available on demand at 10:00 a.m. ET on Monday, November 22, 2021
JMP Securities Hematology & Oncology Summit on Monday, December 6, 2021; fireside chat at 10:20 a.m. ET
Jefferies Denver Healthcare Summit on Wednesday, December 15, 2021
A live webcast and replay of pre-recorded fireside chats will be accessible in the Investors & Media section of Bicycle’s website at www.bicycletherapeutics.com. Archived replays of the webcasts will be available for 30 days following the fireside chat dates.